ELLIPTIC LABORATORIES ASA (ELABS.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:ELABS - NO0010722283 - Common Stock

5.02 NOK

-0.12 (-2.33%)

Last: 1/29/2026, 12:59:29 PM

Fundamental Rating

Taking everything into account, ELABS scores 4 out of 10 in our fundamental rating. ELABS was compared to 114 industry peers in the Software industry. The financial health of ELABS is average, but there are quite some concerns on its profitability. ELABS is not priced too expensively while it is growing strongly. Keep and eye on this one!

Quickly go to:

1. Profitability

1.1 Basic Checks

ELABS had negative earnings in the past year.
ELABS had a positive operating cash flow in the past year.
In the past 5 years ELABS reported 4 times negative net income.
ELABS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -1.61%, ELABS is not doing good in the industry: 61.40% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -1.74%, ELABS is doing worse than 60.53% of the companies in the same industry.
ELABS has a Return On Invested Capital (1.48%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-1.74%
ROIC	1.48%

ROA(3y)-5.97%

ROA(5y)-5.33%

ROE(3y)-6.62%

ROE(5y)-5.96%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 4.35%, ELABS perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
ELABS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	4.35%
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELABS is destroying value.
Compared to 1 year ago, ELABS has more shares outstanding
Compared to 5 years ago, ELABS has more shares outstanding
The debt/assets ratio for ELABS has been reduced compared to a year ago.

2.2 Solvency

A Debt/Equity ratio of 0.03 indicates that ELABS is not too dependend on debt financing.
ELABS has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. ELABS outperforms 83.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACC0.16

WACC8.97%

2.3 Liquidity

ELABS has a Current Ratio of 9.66. This indicates that ELABS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ELABS (9.66) is better than 94.74% of its industry peers.
A Quick Ratio of 9.66 indicates that ELABS has no problem at all paying its short term obligations.
ELABS's Quick ratio of 9.66 is amongst the best of the industry. ELABS outperforms 94.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	9.66
Quick Ratio	9.66

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.67% over the past year.
ELABS shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.76%.
Measured over the past years, ELABS shows a very strong growth in Revenue. The Revenue has been growing by 28.29% on average per year.

EPS 1Y (TTM)66.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%175%

Revenue 1Y (TTM)50.76%

Revenue growth 3Y34.19%

Revenue growth 5Y28.29%

Sales Q2Q%49.72%

3.2 Future

ELABS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 124.60% yearly.
Based on estimates for the next years, ELABS will show a very strong growth in Revenue. The Revenue will grow by 28.97% on average per year.

EPS Next Y80.25%

EPS Next 2Y148.6%

EPS Next 3Y124.6%

EPS Next 5YN/A

Revenue Next Year23.81%

Revenue Next 2Y30.32%

Revenue Next 3Y33.38%

Revenue Next 5Y28.97%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ELABS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 10.15, the valuation of ELABS can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELABS indicates a rather cheap valuation: ELABS is cheaper than 90.35% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ELABS to the average of the S&P500 Index (25.83), we can say ELABS is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	10.15

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELABS is valued a bit cheaper than the industry average as 64.91% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	16.22

4.3 Compensation for Growth

ELABS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ELABS's earnings are expected to grow with 124.60% in the coming years.